Magenta Therapeutics, Inc.
MGTA · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $2,733 | $1,234 | $260,454 | $379,925 |
| - Cash | $22,792 | $57,626 | $131,650 | $58,152 |
| + Debt | $1,491 | $29,962 | $0 | $0 |
| Enterprise Value | -$18,568 | -$26,430 | $128,804 | $321,773 |
| Revenue | $6,235 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0% | – | – | – |
| EBITDA | -$101,864 | -$78,977 | -$74,692 | -$78,702 |
| % Margin | -1,633.7% | – | – | – |
| Net Income | -$84,969 | -$72,022 | -$65,560 | -$69,192 |
| % Margin | -1,362.8% | – | – | – |
| EPS Diluted | -21.75 | -23.05 | -1.12 | -1.43 |
| % Growth | 5.6% | -1,958% | 21.7% | – |
| Operating Cash Flow | -$78,180 | -$67,090 | -$59,531 | -$64,023 |
| Capital Expenditures | -$105 | -$314 | -$1,264 | -$400 |
| Free Cash Flow | -$78,285 | -$67,404 | -$60,795 | -$64,423 |